芯瑞達(002983.SZ):從行業發展趨勢、在手研發項目與訂單來看,公司業務增長趨勢有望保持
格隆匯9月6日丨芯瑞達(002983.SZ)於2023年9月5日接受特定對象調研,就“三季度或下半年業務增長趨勢”,公司回覆稱,2023年上半年,公司顯示模組與終端業務,同比分別增長29%與85%,均高於年初股權激勵計劃設定的增長指標。其中:公司今年2季度Mini顯示模組營收環比1季度增長近200%,完成同期預算近150%。
從行業發展趨勢、在手研發項目與訂單來看,公司業務增長趨勢有望保持。若觸及相關指標值,公司將按規定進行披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.